Associations of osseous abnormalities in neurofibromatosis

American Journal of Medical Genetics, Part A

Volumn 143, Issue 12, 2007, Pages 1326-1333

  Alwan, S ^a   Armstrong, L ^a   Joe, H ^a   Birch, P H ^a   Szudek, J ^b   Friedman, J M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Neurofibromatosis 1; NF1; Osteopathy; Short stature; Sphenoid wing; Tibia; Vertebrae

Indexed keywords

ARTICLE; BONE DISEASE; CHILD; DISEASE ASSOCIATION; FEMALE; FIBULA; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SHORT STATURE; SPHENOID; TIBIA; VERTEBRA;

BODY HEIGHT; BONE DISEASES; FEMALE; FIBULA; HUMANS; LOGISTIC MODELS; MALE; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; ODDS RATIO; SPHENOID BONE; SPINE; TIBIA;

EID: 34249867658     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31754     Document Type: Article

References (57)

1. Ali MS, Hooper G. 1982. Congenital pseuclarthrosis of the ulna due to Neurofibromatosis. J Bone Joint Surg 64:600-602.
2. Alwan S, Tredwell SJ, Friedman JM. 2005. Is osseous dysplasia a primary feature of Neurofibromatosis 1 (NF1)? Clin Genet 67: 378-390.
3. Ashford J, Sowden R. 1970. Multivariate probil analysis. Biometrics 26:535-546.
4. Bensaid AH, Dietemann JL, Kastler B, Gangi A, Jeung MY, Wackenheim A. 1992. Neurofibromatosis with dural ectasia and bilateral symmetrical pedicular clefts: Report of two cases. Neuroradiology 34:107-109.
5. Binet EF, Kieffer SA, Martin SH, Peterson HO. 1969. Orbital dysplasia in Neurofibromatosis. Radiology 93:829-833.
6. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. 1988. Cranial MR imaging in Neurofibromatosis. AJR Am J Roentgenol 151:381-388.
7. Boyd HB. 1982. Pathology and natural history of congenital pseudarthrosis of the tibia. Clin Orthop 166:5-13.
8. Brunetti-Pierri N, Phan K, Carter S, Lewis RA, Plon S, Ellis KJ, O'Briann SE, Lee B. 2003. Generalized osteopenia in Neurofibromatosis Type 1 patients points to an underlying disorder of skeletal homeostatis and mineralization. Am J Hum Genet 73(Supplement):261.
9. Cheema J, Grissom LE, Harcke HT. 2003. Radiographic characteristics of lower-extremity bowing in children. Radiographics 112:289-297.
10. Clauser L, Carniei F, Galie M. 1998. Neurofibromatosis of the orbit and skull base. J Craniofac Surg 9:280-284.
11. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi R. 1999. Neurofibromatosis Type 1 growth charts. Am J Med Genet 87:317-323.
12. Crawford AH, Bagamery N. 1986. Osseous manifestations of Neurofibromatosis in childhood. J Pediatr Orthop 6:72-88.
13. Crawford AH, Schorry EK. 1999. Neurofibromatosis in children: The role of the orthopaedist. J Am Acad Orthop Surg 7:217-230.
14. DeBella K, Szudek J, Friedman JM. 2000. Use of the National Institutes of Health Criteria for diagnosis of Neurofibromatosis 1 in children. Pediatrics 105:608-614.
15. Drevelengas A, Kalaitzoglou I. 1995. Giant lumbar meningocele in a patient with Neurofibromatosis. Neuroradiology 37:195-197.
16. Durrani AA, Crawford AH, Chouhdry SN, Saifuddin A, Morley TR. 2000. Modulation of spinal deformities in patients with Neurofibromatosis type 1. Spine 25:69-75.
17. Easton DF, Ponder MA, Huson SM, Ponder BA. 1993. An analysis of variation in expression of Neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes. Am J Hum Genet 53:305-313.
18. Egelhoff JC, Ross JS, Modic MT, Masaiyk TJ, Estes M. 1992. MR imaging of metastatic GI adenocarcinoma in brain. AJNR Am J Neuroradiol 13:1221-1224.
19. Floyd A, Percy-Lancaster R. 1987. The elephant woman. Neurofibromatosis associated with pseudarthrosis of the humerus. J Bone Joint Surg 69:121-123.
20. Friedman JM. 1999. Epidemiology of Neurofibromatosis Type 1. Am J Med Genet 89:1-6.
21. Friedman JM, Birch PH. 1997. Type 1 Neurofibromatosis: A descriptive analysis of the disorder in 1,728 Patients. Am J Med Genet 70:138-143.
22. Friedman JM, Riccardi VM. 1999. Clinical and epidemiological features. In: Friedman JM, Gutmann D, MacCollin M, Riccardi VM, editors. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore: Johns Hopkins University Press, p 29-86.
23. Friedman JM, Birch P, Greene C. 1993. National Neurofibromatosis Foundation International Database. Am J Med Genet 45:88-91.
24. Gregg PJ, Price BA, Ellis HA, Stevens J. 1982. Pseudarthrosis of the radius associated with neurofibromatosis. A case report. Clin Orthop Relat Res 171:175-179.
25. Gutmann DH, Aylsworth A, Carey JC. et al. 1997. The diagnostic evalulation and multidisciplinary management of Neurofibromatosis 1 and Neurofibromatosis 2. JAMA 278:51-57.
26. Hefti F, Bollini G, Dungl P, Fixen J, Grill F, Ippolito E, Romanus B, Tudisco C, Wientroub S. 2000. Congenital pseudarthrosis of the tibia: History, etiology, classification, and epidemiological data. J Pediatr Orthop B 9:11-15.
27. Hermanns-Sachweh B, Senderek J, Alfer J, Klosterhalfen B, Buttner R, Fuzesi L, Weber M. 2005. Vascular changes in the periosteum of congenital pseudarthrosis of the tibia. Pathol Res Pract 201:305-312.
28. Ippolito E, Corsi A, Grill F, Wientroub S, Bianco P. 2000. Pathology of bone lesions associated with congenital pseudarthrosis of the leg. J Pediatr Orthop B 9:3-10.
29. Jacquemin C, Bosley TM, Liu D, Svedberg H, Buhaliqa A. 2002. Reassessment of sphenoid dysplasia associated with Neurofibromatosis type 1. AJNR Am J Neuroradiol 23:644-648.
30. Keret ID, Bollini G, Dungl P, Fixsen J, Grill F, Hefti F, Ippolito E, Romanus B, Tudisco C, Wientroub S. 2000. The fibula in congenital pseudoarthrosis of the tibia: The EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9:69-74.
31. Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J. 2004a. NF1 tumour suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embtyos. J Bone Miner Res 19:983-989.
32. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J. 2004b. Decreased bone mineral density and content in Neurofibromatosis type 1: Lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928-936.
33. Lammert M, Friedman JM, Kluwe L, Mautner VF. 2005a. Prevalence of Neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 141:71-74.
34. Lammert M, Kappler M, Mautner VF, Lammert K, Storkel S, Friedman JM, Atkins D. 2005b. Decreased bone mineral density in patients with Neurofibromatosis 1. Osteoporos Int 16:1161-1166.
35. Maefarlane R, Levin AV, Weksberg R, Blaser S, Rutka JT. 1995. Absence of the greater sphenoid wing in Neurofibromatosis type I: Congenital or acquired: Case report. Neurosurgery 37:129-133.
36. McGaughran JM, Harris DI, Donnai D, Teare D, MacLeod R, Westerbeek R, Kingston H, Super M, Harris R, Evans DG. 1999. A clinical study of tvpe 1 Neurofibromatosis in north west England. J Med Genet 36:197-203.
37. Myrianthopoulos NC. 1977. Other skull defects: Craniolacunia, foramina parietalia permagna, aplasia of the sphenoid wings. In: Vinken PG, Bruyn GW, editors. Handbook of clinical neurology. Amsterdam: Elsevier, p 269-284.
38. NIH. 1988. Neurofibromatosis: Conference Statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575-578.
39. Ohnishi I, Sato W, Matsuyama J, Yajima H, Haga N, Kamegaya M, Minami A, Sato M, Yoshino S, Oki T, Nakamura K. 2005. Treatment of congenital pseudarthrosis of the tibia: A multicenter study in Japan. J Pediatr Orthop 25:219-224.
40. Palmer C, Szudek J, Joe H, Riccardi VM, Friedman JM. 2004. Analysis of Neurofibromatosis (NF1) lesions by body segment. Am J Med Genet Part A 125A:157-161.
41. Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, Rojiani AM, Maria BL, Muir D, Wallace MR. 2000. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in Neurofibromatosis type 1. Genes Chromosomes Cancer 28:425-431.
42. Riccardi VM. 1992. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. 2nd edn. Baltimore: Johns Hopkins University Press.
43. Riccardi VM. 1999. Skeletal system. In: Friedman JM, Gutmann D, MacCollin M, Riccardi VM, editors. Neurofibromatosis: Phenotype, Natural History and Pathogenesis. 3rd edn. Baltimore: Johns Hopkins University Press.
44. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C. 1997. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519.
45. Sirosis JL, Drennan JC. 1990. Dystrophic spinal deformity in Neurofibromatosis. J Pediatr Orthop 10:522-526.
46. Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, Buske A, Korf BR, Niimura M, Pivnick EK, Schorry EK, Short MP, Tenconi R, Tonsgard JH, Carey JC. 1999. Descriptive analysis of tibial pseudarthrosis in patients with Neurofibromatosis 1. Am J Med Genet 84:413-419.
47. Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D'Astous JL, Santora SD, Viskochil DH. 2006. Double inactivation of NF1 in tibial pseudoarthrosis. Am J Hum Genet 79:143-148.
48. Szudek J, Birch P, Friedman JM. 2000a. Growth in North American white children with Neurofibromatosis 1 (NF1). J Med Genet 37:933-938.
49. Szudek J, Birch P, Riccardi VM, Evans DG, Friedman JM. 2000b. Associations of clinical features in Neurofibromatosis 1 (NF1). Genet Epidemiol 19:429-439.
50. Szudek J, Joe H, Friedman JM. 2002. Analysis of intrafamilial phenotypic variations in Neurofibromatosis 1 (NF1). Genet Epidemiol 23:150-164.
51. SzudekJ, Evans DG, Friedman JM. 2003. Patterns of associations of clinical features in Neurofibromatosis 1 (NF1). Hum Genet 112:289-297.
52. Tubbs RS, Oakes WJ. 2002. Dura ectasia in Neurofibromatosis. Pediatr Neurosurg 37:331-332.
53. Tucker T, Friedman JM. 2002. Pathogenesis of hereditary tumors: Bevond the "two-hit" hypothesis. Clin Genet 62:345-357.
54. Vitale MG, Guha A, Skaggs DL. 2002. Orthopedic manifestations of Neurofibromatosis in children. An update. Clin Orthop 401: 107-118.
55. Von-Deimling A, Krone W, Menon AG. 1995. Neurofibromatosis type 1: Pathology, clinical features and molecular genetics. Brain Pathol 5:153-162.
56. White AK, Smith RJ, Bigler CR, Brooke WF, Schauer PR. 1986. Head and neck manifestations of Neurofibromatosis. Laryngoscope 96:732-737.
57. Xu GF, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, Stevens J, Gesteland R, White R, et al. 1990. The Neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.